4
Changes in Ownership
PRECISION BIOSCIENCES INC Filed Acc 0001209191-21-012745
President and CEO sold 9,705 shares at $12.23 ($118,692)
- President and CEO acquired 21,514 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KANE MATTHEW R. President and CEO | 2021-02-18 | Option exercise | +21,514 | $0.04 | $861 | 1,899,151 | D: show line 1 in the form |
| KANE MATTHEW R. President and CEO | 2021-02-18 | Sale | −9,705 | $12.23 | $118,692 | 1,889,446 | D: show line 2 in the form |
| Open-market sales · 9,705 sh · avg $12.23 · $118,692 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KANE MATTHEW R. President and CEO | 2021-02-18 | Option exercise · Employee Stock Option (Right to Buy) | −21,514 | 193,626 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…